Phase II AutoImmune Hepatitis

PHASE2WithdrawnINTERVENTIONAL
0
Timeline

Start Date

January 1, 2019

Primary Completion Date

November 1, 2019

Study Completion Date

December 31, 2019

Conditions
Hepatitis, Autoimmune
Interventions
DRUG

Synthetic PreImplantation Factor

peptide

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

BioIncept LLC

INDUSTRY

lead

Christopher O'Brien, MD

OTHER

NCT03593460 - Phase II AutoImmune Hepatitis | Biotech Hunter | Biotech Hunter